CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Yaras Brandon Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +410,000 | 410,000 | ||
| 2026-05-27 | SCHIMMEL PAUL Director | Purchase | +100,000 | $0.50 | $50K | 779,143 |
| 2026-05-11 | Lucas Svetlana Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-05-11 | Gross Jane A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-05-11 | BENEVICH ERIC Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-05-11 | Zaknoen Sara Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-05-11 | Coughlin Timothy Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-05-11 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-02-04 | Shukla Sanjay President and CEO | Sale | −3,745 | $0.98 | $4K | 153,553 |
| 2026-02-04 | Broadfoot Jill Marie Chief Financial Officer | Sale | −1,558 | $0.98 | $2K | 37,296 |
| 2026-02-04 | DENYES NANCY General Counsel | Sale | −1,118 | $0.98 | $1K | 33,124 |
| 2026-02-03 | Shukla Sanjay President and CEO | Option exercise | +10,375 | 157,298 | ||
| 2026-02-03 | Shukla Sanjay President and CEO | Option exercise · Restricted Stock Unit | −10,375 | 0 | ||
| 2026-02-03 | Broadfoot Jill Marie Chief Financial Officer | Option exercise | +3,750 | 38,854 | ||
| 2026-02-03 | Broadfoot Jill Marie Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,750 | 0 | ||
| 2026-02-03 | DENYES NANCY General Counsel | Option exercise | +2,687 | 34,242 | ||
| 2026-02-03 | DENYES NANCY General Counsel | Option exercise · Restricted Stock Unit | −2,687 | 0 | ||
| 2026-01-09 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +1,500,000 | 1,500,000 | ||
| 2026-01-09 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +412,500 | 412,500 | ||
| 2026-01-09 | DENYES NANCY General Counsel | Grant or award · Employee Stock Options (right to buy) | +412,500 | 412,500 |
Page 1 of 15 · 284 trades